|Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines|
K Kisand, AS Bøe Wolff, KT Podkrajšek, L Tserel, M Link, KV Kisand, ...
Journal of Experimental Medicine 207 (2), 299-308, 2010
|Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cells|
O Bruserud, C Stapnes, E Ersvaer, BT Gjertsen, A Ryningen
Current pharmaceutical biotechnology 8 (6), 388-400, 2007
|The proteasome inhibitors bortezomib and PR‐171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells|
C Stapnes, AP Døskeland, K Hatfield, E Ersvær, A Ryningen, JB Lorens, ...
British journal of haematology 136 (6), 814-828, 2007
|Toombak use and cigarette smoking in the Sudan: estimates of prevalence in the Nile state|
AM Idris, YE Ibrahim, K Warnakulasuriya, DJ Cooper, NW Johnson, ...
Preventive medicine 27 (4), 597-603, 1998
|Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC 1, TH 1, TH 17 and T REG cells|
E Ersvaer, K Liseth, J Skavland, BT Gjertsen, Ø Bruserud
BMC immunology 11 (1), 1-12, 2010
|Heat shock protein 90-a potential target in the treatment of human acute myelogenous leukemia|
H Reikvam, E Ersvaer, O Bruserud
Current cancer drug targets 9 (6), 761-776, 2009
|Primary human acute myeloid leukaemia cells increase the proliferation of microvascular endothelial cells through the release of soluble mediators|
K Hatfield, AM Øyan, E Ersvaer, KH Kalland, P Lassalle, BT Gjertsen, ...
British journal of haematology 144 (1), 53-68, 2009
|The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity|
E Ersvaer, AO Kittang, P Hampson, K Sand, BT Gjertsen, JM Lord, ...
Toxins 2 (1), 174-194, 2010
|Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2: Bax ratio and …|
A Ryningen, E Ersvær, AM Øyan, KH Kalland, OK Vintermyr, BT Gjertsen, ...
Leukemia research 30 (12), 1531-1540, 2006
|Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status …|
H Reikvam, KJ Hatfield, E Ersvær, R Hovland, J Skavland, BT Gjertsen, ...
British journal of haematology 156 (4), 468-480, 2012
|The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia|
H Fredly, E Ersvær, AO Kittang, G Tsykunova, BT Gjertsen, Ø Bruserud
Clinical epigenetics 5 (1), 1-15, 2013
|Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and …|
H Reikvam, KJ Hatfield, P Lassalle, A Olsnes Kittang, E Ersvær, ...
Expert opinion on investigational drugs 19 (2), 169-183, 2010
|Long‐term cryopreservation of autologous stem cell grafts: a clinical and experimental study of hematopoietic and immunocompetent cells|
K Liseth, E Ersvær, JF Abrahamsen, I Nesthus, A Ryningen, Ø Bruserud
Transfusion 49 (8), 1709-1719, 2009
|Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I|
ASB Wolff, BEV Oftedal, K Kisand, E Ersvaer, K Lima, ES Husebye
Scandinavian journal of immunology 71 (6), 459-467, 2010
|Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia‐associated antigen associated with autoantibody …|
E Ersvaer, JY Zhang, E McCormack, A Olsnes, N Ånensen, E M. Tan, ...
European Journal of Haematology 79 (3), 210-225, 2007
|Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis|
H Fredly, E Ersvær, BT Gjertsen, Ø Bruserud
Oncology reports 25 (6), 1549-1556, 2011
|Interleukin-6 in allogeneic stem cell transplantation: its possible importance for immunoregulation and as a therapeutic target|
THA Tvedt, E Ersvaer, AA Tveita, Ø Bruserud
Frontiers in immunology 8, 667, 2017
|Antileukaemic effect of PI 3 K‐m TOR inhibitors in acute myeloid leukaemia‐gene expression profiles reveal CDC 25 B expression as determinate of pharmacological effect|
H Reikvam, J Tamburini, S Skrede, R Holdhus, L Poulain, E Ersvær, ...
British journal of haematology 164 (2), 200-211, 2014
|The protein kinase C agonist PEP005 increases NF‐κB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells|
AM Olsnes, E Ersvær, A Ryningen, K Paulsen, P Hampson, JM Lord, ...
British journal of haematology 145 (6), 761-774, 2009
|The chemokine system in allogeneic stem-cell transplantation: a possible therapeutic target?|
GK Melve, E Ersvaer, AO Kittang, Ø Bruserud
Expert Review of Hematology 4 (5), 563-576, 2011